Goldman Sachs' Earnings Woes, X Tests Subscri...

Scott-Free August continues, and Kara sits down with Mark Cuban — entrepreneur and co-founder of Cost Plus Drugs. They dig into why prescription drug prices are finally falling, Cuban's war with the healthcare industry, and Costco's surprising Medicare play. Then: why Cuban think ...  Show more

Kara kicks off another week of Scott-Free August! Gen Z political commentator Adam Mockler is in the guest host chair to discuss the growing fallout over conditions aboard the USS Abraham Lincoln, and Jon Ossoff’s swipe at Trump and his aide Natalie Harp. Plus, Democrats shake up ...  Show more

Scott and Ed open the show by discussing the U.S.’s GDP growth, Reddit’s earnings, Eli Lilly’s third quarter drug sales, and xAI’s new funding round. Then Scott and Ed break down big tech’s earnings and discuss how the tech companies are using capital as a weapon. They also exami ...  Show more

Goldman Sachs’ profits plunged by two-thirds last quarter while Morgan Stanley reported a 40 per cent year-on-year drop in net income, and companies are facing a record number of shareholder proposals about abortion policies. Plus, Beijing is changing tack in its efforts to se ...

This week, with big developments in two antitrust cases against Google, we discuss how the company may be forced to change its business. Then we’re joined by the journalist Mark Yarm to discuss his recent visit to an underwater home for his article about techno-utopians who wa ...

HSBC’s top-paid bankers to bear the brunt of cost-cutting restructuring, and the UK Conservative party leadership race has been whittled down to two rightwingers. Plus, Germany’s economy is expected to shrink, and the US government is considering seeking the break-up of Google ...